Topical ophthalmic lipid nanoparticle formulations (SLN, NLC) of indomethacin for delivery to the posterior segment ocular tissues.
about
Ocular disposition of ciprofloxacin from topical, PEGylated nanostructured lipid carriers: Effect of molecular weight and density of poly (ethylene) glycol.Approaches in topical ocular drug delivery and developments in the use of contact lenses as drug-delivery devices.Application of nanostructured lipid carriers: the prolonged protective effects for sesamol in in vitro and in vivo models of ischemic stroke via activation of PI3K signalling pathway.Novel cationic lipid nanoparticles as an ophthalmic delivery system for multicomponent drugs: development, characterization, in vitro permeation, in vivo pharmacokinetic, and molecular dynamics studies.Recent advances in topical nano drug-delivery systems for the anterior ocular segment.[Nanoparticles as drug delivery systems in ophthalmology].Innovative Nanoparticles Enhance N-Palmitoylethanolamide Intraocular Delivery.A pH-independent instantaneous release of flurbiprofen: a study of the preparation of complexes, their characterization and in vitro/in vivo evaluation.Tanshinol borneol ester on nanostructured lipid carriers has longer brain and systemic effector retention and better antioxidant activity in vivo.Ocular Delivery System for Propranolol Hydrochloride Based on Nanostructured Lipid Carrier.Lipid nanoparticles loading triptolide for transdermal delivery: mechanisms of penetration enhancement and transport properties
P2860
Q38716544-24BCFEF3-6750-47EF-A915-651AC77CE387Q39386513-5F06A90E-D368-47F2-9076-4B47B585C8C0Q47109763-91729FFE-00A0-45EC-AE4F-CED34BEFD117Q47143814-F598C852-B2CA-4B29-8B27-60E8257E3DA5Q50082031-A7FACD07-9468-46D7-B5E7-A6F959B23513Q50129671-9932070D-89DE-4C86-BBC2-387148104B02Q52592946-4CE19B4C-001C-4F73-A205-43F831D29D32Q54527581-4F8F1129-21CE-4094-B8BD-81A66FABF559Q55003285-04AF126B-3CB9-42CE-817E-2C866B1D18BFQ55471051-19ACE028-C5BF-4AE3-B723-B8229324CC7CQ58737777-C2E0AEDD-E236-4DF3-8E81-C24FCE9252AF
P2860
Topical ophthalmic lipid nanoparticle formulations (SLN, NLC) of indomethacin for delivery to the posterior segment ocular tissues.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh-hant
name
Topical ophthalmic lipid nanop ...... terior segment ocular tissues.
@en
Topical ophthalmic lipid nanop ...... terior segment ocular tissues.
@nl
type
label
Topical ophthalmic lipid nanop ...... terior segment ocular tissues.
@en
Topical ophthalmic lipid nanop ...... terior segment ocular tissues.
@nl
prefLabel
Topical ophthalmic lipid nanop ...... terior segment ocular tissues.
@en
Topical ophthalmic lipid nanop ...... terior segment ocular tissues.
@nl
P2860
P1476
Topical ophthalmic lipid nanop ...... terior segment ocular tissues.
@en
P2093
Sai Prachetan Balguri
Soumyajit Majumdar
P2860
P304
P356
10.1016/J.EJPB.2016.10.015
P407
P577
2016-10-25T00:00:00Z